BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
BEGIN:VEVENT
UID:2aebe70c28abbff918a6bc6be6e9404d
DTSTAMP:20260727T165731Z

DTSTART:20260303T150000
DTEND:20260303T150000
SUMMARY:Turning challenge into opportunity: partnership models for sustained HIV vaccine research
DESCRIPTION:On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the future of HIV vaccine research in a shifting funding landscape.\nDespite significant progress in HIV prevention and treatment, persistent inequities, emerging drug resistance, and recent global funding cuts continue to threaten advances — underscoring the urgent need for an effective HIV vaccine.\nThe session will explore how innovative multi-stakeholder partnerships — spanning governments, funders, African research institutions, and communities — can sustain and strengthen HIV vaccine R&amp;D. Speakers will highlight successful partnership models, key funding and governance lessons, and strategies to advance African-led leadership and long-term investment in the next generation of HIV vaccines.\nParticipants will also learn how collaborative approaches can transform current challenges into opportunities for resilient, equitable research systems. 🤝

X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">\n<HTML>\n<HEAD>\n<META NAME="Generator" CONTENT="MS Exchange Server version 08.00.0681.000">\n<TITLE></TITLE>\n</HEAD>\n<BODY>\n<!-- Converted from text/rtf format -->\n\n<p>On 3 March 2026 (15:00 CET), this IAS–IAVI Timely Topic Webinar will bring together global stakeholders to discuss the future of HIV vaccine research in a shifting funding landscape.</p><br /><p>Despite significant progress in HIV prevention and treatment, persistent inequities, emerging drug resistance, and recent global funding cuts continue to threaten advances — underscoring the urgent need for an effective HIV vaccine.</p><br /><p>The session will explore how innovative multi-stakeholder partnerships — spanning governments, funders, African research institutions, and communities — can sustain and strengthen HIV vaccine R&amp;D. Speakers will highlight successful partnership models, key funding and governance lessons, and strategies to advance African-led leadership and long-term investment in the next generation of HIV vaccines.</p><br /><p>Participants will also learn how collaborative approaches can transform current challenges into opportunities for resilient, equitable research systems. 🤝</p>\n\n</BODY>\n</HTML>

LOCATION:
END:VEVENT

END:VCALENDAR
